Nilotinib-induced psoriasis in a patient of chronic myeloid leukemia responding to methotrexate

被引:4
|
作者
Kaur, Sukhjot [1 ]
Arora, Amanjot Kaur [1 ]
Sekhon, Jagdev S. [2 ]
Sood, Neena [3 ]
机构
[1] Dayanand Med Coll & Hosp, Dept Dermatol & Venereol, Div Oncol, Ludhiana, Punjab, India
[2] Dayanand Med Coll & Hosp, Dept Internal Med, Div Oncol, Ludhiana, Punjab, India
[3] Dayanand Med Coll & Hosp, Dept Pathol, Ludhiana, Punjab, India
来源
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY | 2015年 / 81卷 / 02期
关键词
REGULATORY T-CELLS; GASTROINTESTINAL STROMAL TUMOR; CHRONIC MYELOGENOUS LEUKEMIA; IMATINIB-RESISTANT; PROLIFERATION; PATHOGENESIS; MANAGEMENT; INHIBITORS; DASATINIB;
D O I
10.4103/0378-6323.152311
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:216 / 218
页数:3
相关论文
共 50 条
  • [41] Comparison of Dasatinib, Nilotinib, and Imatinib in the Treatment of Chronic Myeloid Leukemia
    Ciarcia, Roberto
    Damiano, Sara
    Puzio, Maria Valeria
    Montagnaro, Serena
    Pagnini, Francesco
    Pacilio, Carmen
    Caparrotti, Giuseppe
    Bellan, Cristiana
    Garofano, Tiziana
    Polito, Maria Sole
    Giordano, Antonio
    Florio, Salvatore
    JOURNAL OF CELLULAR PHYSIOLOGY, 2016, 231 (03) : 680 - 687
  • [42] Nilotinib: evaluation and analysis of its role in chronic myeloid leukemia
    Garland, Paula
    Apperley, Jane
    FUTURE ONCOLOGY, 2011, 7 (02) : 201 - 218
  • [43] Satisfaction with information on nilotinib treatment in chronic myeloid leukemia patients
    Boons, Christel C. L. M.
    Tromp, Vashti N. M. F.
    Neppelenbroek, Nienke J. M.
    Timmers, Lonneke
    van Schoor, Natasja M.
    Swart, Eleonora L.
    Hendrikse, N. Harry
    Janssen, Jeroen J. W. M.
    Hugtenburg, Jacqueline G.
    ACTA ONCOLOGICA, 2019, 58 (06) : 891 - 896
  • [44] Nilotinib as first-line therapy for chronic myeloid leukemia
    Vaid, A.
    INDIAN JOURNAL OF CANCER, 2011, 48 (04) : 438 - 445
  • [45] Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
    Saglio, Giuseppe
    Kim, Dong-Wook
    Issaragrisil, Surapol
    le Coutre, Philipp
    Etienne, Gabriel
    Lobo, Clarisse
    Pasquini, Ricardo
    Clark, Richard E.
    Hochhaus, Andreas
    Hughes, Timothy P.
    Gallagher, Neil
    Hoenekopp, Albert
    Dong, Mei
    Haque, Ariful
    Larson, Richard A.
    Kantarjian, Hagop M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24): : 2251 - 2259
  • [46] Nilotinib for the frontline treatment of Ph+ chronic myeloid leukemia
    Rosti, Gianantonio
    Palandri, Francesca
    Castagnetti, Fausto
    Breccia, Massimo
    Levato, Luciano
    Gugliotta, Gabriele
    Capucci, Adele
    Cedrone, Michele
    Fava, Carmen
    Intermesoli, Tamara
    Cambrin, Giovanna Rege
    Stagno, Fabio
    Tiribelli, Mario
    Amabile, Marilina
    Luatti, Simona
    Poerio, Angela
    Soverini, Simona
    Testoni, Nicoletta
    Martinelli, Giovanni
    Alimena, Giuliana
    Pane, Fabrizio
    Saglio, Giuseppe
    Baccarani, Michele
    BLOOD, 2009, 114 (24) : 4933 - 4938
  • [47] Comparison of the Efficacy of Nilotinib and Imatinib in the Treatment of Chronic Myeloid Leukemia
    Zhang, Bang-Shuo
    Chen, Yong-Ping
    Lv, Jing-Long
    Yang, Yi
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2019, 29 (07): : 631 - 634
  • [48] The Imatinib and Nilotinib Induced Modulation of the Proteasomal Activity and Antigen Processing in Chronic Myeloid Leukemia Cells
    Held, Stefanie A. E.
    Heine, Annkristin
    Tenzer, Stefan
    Bringmann, Anita
    Schild, Hansjoerg
    Driessen, Christoph
    Brossart, Peter
    BLOOD, 2011, 118 (21) : 1181 - 1182
  • [49] Psoriasis and chronic myeloid leukemia: treatment with Apremilast
    Vico-Alonso, Cristina
    Sanchez-Velazquez, Alba
    Pinilla-Martin, Belen
    Andres-Lencina, Juan-Jose
    Aragon-Miguel, Raquel
    Calleja-Algarra, Alba
    Rivera-Diaz, Raquel
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (04) : E102 - E103
  • [50] CLINICAL ASPECTS OF NILOTINIB USE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN THE CHRONIC PHASE
    Gusarova, G. A.
    Turkina, A. G.
    Kolosheinova, T. I.
    Vakhrusheva, M. V.
    Chelysheva, E. Yu.
    Zakharova, E. S.
    Kuznetsov, S. V.
    Nemchenko, I. S.
    Sokolova, M. A.
    Goryacheva, S. R.
    Lazareva, O. V.
    Bykova, A. V.
    Tkhai, N. V.
    Khoroshko, N. D.
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2012, 57 (04): : 3 - 11